ASA: Adjuvant Methylprednisolone Role Examined in Acute Ischemic Stroke
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Feb. 14, 2024 -- For patients with acute ischemic stroke secondary to large-vessel occlusion (LVO) undergoing endovascular thrombectomy, adjuvant low-dose methylprednisolone does not improve the degree of overall disability, according to a study published online Feb. 8 in the Journal of the American Medical Association to coincide with the annual American Stroke Association International Stroke Conference, held from Feb. 7 to 9 in Phoenix.
Qingwu Yang, M.D., Ph.D., from Army Medical University in Chongqing, China, and colleagues examined the efficacy and adverse events of adjunctive intravenous low-dose methylprednisolone to endovascular thrombectomy for acute ischemic stroke secondary to LVO in a placebo-controlled trial implemented at 82 hospitals. Eligible patients were randomly assigned to intravenous methylprednisolone at 2 mg/kg/day or placebo (839 and 841, respectively) for three days.
The researchers found that the median 90-day modified Rankin Scale score was 3 in both groups. The mortality rate was lower in the methylprednisolone group than the placebo group (23.2 versus 28.5 percent; adjusted risk ratio, 0.84), and the rate of symptomatic intracranial hemorrhage was also lower (8.6 versus 11.7 percent; adjusted risk ratio, 0.74).
"This study is therefore one of the first, to our knowledge, to provide evidence regarding the potential role of corticosteroid therapy in the setting of endovascular stroke reperfusion," the authors write.
Several authors disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Read this next
Delay in Hospital Arrival After Stroke Linked to Social Vulnerability
THURSDAY, May 30, 2024 -- Areas with a high incidence of delay in hospital arrival after ischemic stroke are characterized by increased social vulnerability, according to a study...
Infarct Size Does Not Affect Treatment Effect of Early Versus Late DOAC
TUESDAY, May 28, 2024 -- For individuals with minor, moderate, or major stroke, the treatment effect of early versus late direct oral anticoagulant (DOAC) initiation does not...
Extreme Temperatures Linked to Increased Risk for Stroke Death
FRIDAY, May 24, 2024 -- Extreme cold and hot temperatures are associated with an increased risk for death from ischemic and hemorrhagic strokes, according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.